The world’s first cannabinoid-based antitumor Drug Candidate for the treatment of Colorectal Cancer based on our novel and proprietary formulation Cannabics™ RCC-33
of cancer related cannabinoid-based therapeutic
formulations and medicines
PIONEER IN CANNABINOID-BASED ANTITUMOR RESEARCH
Cannabics Pharmaceuticals has been
conducting research on the antitumor effects of
cannabinoid formulations on cancer since its
establishment in 2012.
Cannabics Pharmaceuticals’ groundbreaking research and development is carried in its in-house state of the art drug discovery facility.
Cannabics TM CDx
Drug Sensitivity Test
for matching a specific medical
to a specific patient
Cannabics TM SR
Drug Candidate for the treatment of
Cancer Related Anorexia-Cachexia